Prostate-specific antigen (PSA) screening for prostate cancer remains a controversial topic, particularly in the primary care community. Our multidisciplinary prostate screening panel at Duke University Health System, USA created a nuanced PSA screening algorithm, implemented it into the Electronic Health Record of Duke Primary Care, and conducted outreach meetings with primary care practices to support its rollout. Through this project, we identified areas of concern among primary care clinicians regarding PSA screening that we structured into two major categories: ideological opposition and logistical opposition. We outlined specific concerns in each major category and described how our team responded to those concerns. As communication b...
Since widespread prostate cancer screening was introduced in the United States in the late 1980s and...
screening: should family physicians discuss it with their patients? Iread the recent editorial1 on p...
Recently, several prospective randomized prostate cancer screening studies have been reported. We re...
Since 2012, multiple new guidelines have been issued advising changes in screening for prostate canc...
ObjectiveProstate specific antigen (PSA) screening for prostate cancer screening is not uniformly re...
This Viewpoint discusses the feasibility of shared decision making among primary care physicians and...
Prostate cancer screening is an ever-changing field because the benefits of using PSA as a screening...
Background: Limited information exists on primary care physicians’ (PCPs) use of the prostate-specif...
it mildly, prostate cancer screening and treatment has been a contentious issue over the past year. ...
BackgroundShared decision making improves value-concordant decision-making around prostate cancer sc...
Screening for prostate cancer is a highly debated public health issue. The evidence base is conteste...
This study aims to examine the current practice of General practitioners (GPs)/primary care physicia...
This study aims to examine the current practice of General practitioners (GPs)/primary care physicia...
Recently, several prospective randomized prostate cancer screening studies have been reported. We re...
Objectives: Describe the epidemiological features of prostate cancer Be familiar with the two larg...
Since widespread prostate cancer screening was introduced in the United States in the late 1980s and...
screening: should family physicians discuss it with their patients? Iread the recent editorial1 on p...
Recently, several prospective randomized prostate cancer screening studies have been reported. We re...
Since 2012, multiple new guidelines have been issued advising changes in screening for prostate canc...
ObjectiveProstate specific antigen (PSA) screening for prostate cancer screening is not uniformly re...
This Viewpoint discusses the feasibility of shared decision making among primary care physicians and...
Prostate cancer screening is an ever-changing field because the benefits of using PSA as a screening...
Background: Limited information exists on primary care physicians’ (PCPs) use of the prostate-specif...
it mildly, prostate cancer screening and treatment has been a contentious issue over the past year. ...
BackgroundShared decision making improves value-concordant decision-making around prostate cancer sc...
Screening for prostate cancer is a highly debated public health issue. The evidence base is conteste...
This study aims to examine the current practice of General practitioners (GPs)/primary care physicia...
This study aims to examine the current practice of General practitioners (GPs)/primary care physicia...
Recently, several prospective randomized prostate cancer screening studies have been reported. We re...
Objectives: Describe the epidemiological features of prostate cancer Be familiar with the two larg...
Since widespread prostate cancer screening was introduced in the United States in the late 1980s and...
screening: should family physicians discuss it with their patients? Iread the recent editorial1 on p...
Recently, several prospective randomized prostate cancer screening studies have been reported. We re...